The Medtech Investment Working Group convenes investors, corporate business development executives, and innovators to address issues impacting the medtech investment and the innovation ecosystem, and to create opportunities for networking and business development among AdvaMed members. The Q1 2022 meeting focuses on the diagnostics industry with presentations from Susan Van Meter, Executive Director of AdvaMedDx and a discussion panel on deal-making in diagnostics, featuring Megan Bailey (Head of Personal Genome Diagnostics) Lily Li (Principal, Northpond Ventures), and Prasanth Reddy (Senior Vice President, Global Enterprise and Head of Oncology, Labcorp). A recording of this meeting is available for AdvaMed members.
Hear From Us
Sign up to receive emails highlighting our upcoming events, early registration savings, and engagement opportunities for the medical technology community.